» Articles » PMID: 38181915

Codonopsis Lanceolata Polysaccharide Ameliorates High-fat Diet Induced-postpartum Hypogalactia Via Stimulating Prolactin Receptor-mediated Jak2/Stat5 Signaling

Overview
Publisher Elsevier
Date 2024 Jan 5
PMID 38181915
Authors
Affiliations
Soon will be listed here.
Abstract

This study aims to investigate the ameliorative effect of Codonopsis lanceolata polysaccharide (PCL) on mice with hypogalatia induced by a high-fat diet (HFD) and the potential underlying mechanism. We found that oral administration of PCL demonstrated significant benefits in countering the negative effects of HFD, including weight gain, hepatic steatosis, mesenteric adipocyte hypertrophy, and abnormal glucose/lipid metabolism. In addition, PCL improved mammary gland development and enhanced lactogenesis performance. Histologically, PCL ameliorated the retardation of ductal growth, reduced mammary fat pad thickness, improved the incomplete linear encapsulation of luminal epithelium and myoepithelium, and increased the proliferation of mammary epithelial cells. Flow cytometry analysis showed that PCL mitigated the detrimental effects of HFD on mammary gland development by promoting the proliferation and differentiation of mammary epithelial cells. Mechanistic studies revealed that PCL upregulated the levels of prolactin (PRL) and its receptor (PRLR) in the mammary gland, activated JAK2/STAT5 signaling pathway, and increased the expression of p63, ERBB4, and NRG1. Overall, PCL can ameliorate HFD-induced hypogalactia by activating PRLR-mediated JAK2/STAT5 signaling. Our findings offer a methodological and theoretical foundation for investigating the functional constituents of traditional Chinese medicine in the treatment of hypogalactia.

Citing Articles

Ribosome profiling and single-cell RNA sequencing identify the unfolded protein response as a key regulator of pigeon lactation.

Liu J, Liu S, Mao H, Jiang H, Liu S, Xu X Zool Res. 2025; 46(1):54-74.

PMID: 39846187 PMC: 11890991. DOI: 10.24272/j.issn.2095-8137.2024.336.


Advancements in the investigation of chemical components and pharmacological properties of Codonopsis: A review.

Chu R, Zhou Y, Ye C, Pan R, Tan X Medicine (Baltimore). 2024; 103(26):e38632.

PMID: 38941387 PMC: 11466214. DOI: 10.1097/MD.0000000000038632.


A systematic review of the mechanism of action and potential medicinal value of codonopsis pilosula in diseases.

Guo H, Lou Y, Hou X, Han Q, Guo Y, Li Z Front Pharmacol. 2024; 15:1415147.

PMID: 38803438 PMC: 11128667. DOI: 10.3389/fphar.2024.1415147.